All In MedTech

FDA Clearance Tracker · P020004-S166

GORE EXCLUDER AAA Endoprosthesis

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 5, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 5, 2020

Approved

Time to decision

180 days

Received Aug 9, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P020004-S166
Device name
GORE EXCLUDER AAA Endoprosthesis
Applicant location
Phonix, AZ
Received
Aug 9, 2019
Decided
Feb 5, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P020004

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

Approval for use of an alternate deployment fiber with the Gore EXCLUDER Low-Profile Aortic Extender device component.

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.